Article Listing - LICENSING DEAL FOR LISINOPRIL PRODUCTS
STOCK MARKET COMMENTARY: NEW YORK
13 April 1992
NEW YORK: stock prices climbed throughout nearly the whole rep-orting week, closing with a 40-point or 1.2% rise, following slow...
STOCK MARKET COMMENTARY: TOKYO
13 April 1992
TOKYO: stocks fell sharply again last week on rising volume. The Nikkei Average briefly dipped below 18,000 yen on Monday...
US NEW PRESCRIPTI0N DRUG SALES IN 1991
13 April 1992
The leading new prescription pharmaceutical product in the USA last year was Wyeth-Ayerst's non-steroidal anti-inflammatory drug Lodine (etodolac), which received...
ROCHE CONSOLIDATED PROFIT LEAPS 56% IN 1991
13 April 1992
For 1991, Swiss pharmaceutical major Hoffmann-La Roche reported "continued and significant improvement in the group's earning performance," with consolidated group...
SCHWARZ PHARMA MAKES STRIDES IN EAST GERMANY
13 April 1992
The medium-sized German drugmaker Schwarz Pharma AG has criticized the 25% discount regulation applying to eastern German drugs sales. Board...
ORGANON LAUNCHES PHYSIOGINE IN FRANCE
13 April 1992
Organon has launched Physiogine (estriol), in 0.1% vaginal cream and 0.5mg capsule formulations for the local treatment of post-menopausal symptoms,...
GERMAN DRUG OUTPUT RISES
13 April 1992
The pharmaceutical industry of western Germany increased its production to a significant degree last year, according to the industry association,...
HAFSLUND GOES FOR ITALIAN MARKET
13 April 1992
The Norwegian pharmaceutical and diagnostics company Hafslund Nycomed has started operations in Italy through its Milan-based subsidiary, and is about...
ROCHE'S MICROBIOLOGY DIAGNOSTIC BUSINESS SALE
13 April 1992
The Roche Diagnostics Systems Division of Hoffmann-La Roche and Roche Diagnostics Systems Inc have signed an agreement with Becton Dickin-son...
APPOINTMENTS AT WHITEHALL LABS
13 April 1992
Appointments at Whitehall Labs in the UK: Ray Edwards moves up to marketing director; Paul Hawkins is named as sales...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
